Substance-related disorders are widespread among the general public and
are often accompanied by other psychiatric disorders. However, historical
social stigma and other factors have led to underdiagnosis and limited
access to care. Cost-effective treatment is best delivered in a
comprehensive, flexible continuum of services, which should be accessible
on the same basis as other medical care. The American Psychiatric
Association should continue to promote access to care, high- quality
treatment, education, training, research, parity in third-party coverage,
and equal treatment for patients suffering from addictive disorders. This
statement was drafted by the Task Force on Psychiatric Services for
Addicted Patients. It was approved by the Assembly in November 1995 and by
the Board of Trustees in December 1995.Abstract Teaser